Lipid nanoparticles are the leading delivery vehicle for mRNAs across biomedical applications, each requiring its own nanoparticle design and optimization. In a cover-winning Nature Biotechnology paper, the Anderson and Langer Labs used machine learning approaches to evaluate 1.6 million lipids in silico, to expedite successful designs for mRNA delivery to the lungs in animal models.